Article Details
Retrieved on: 2022-09-11 09:26:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer ...
Article found on: thefacts.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here